Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Indiana Eyes 2027 Medical Cannabis Timeline as Midwest Opens Up
Hoosier State lawmaker drafts medical marijuana bill targeting 2027 implementation, potentially unlocking $200M+ market in holdout jurisdiction.
VA Medical Cannabis Amendment Clears Committee, Eyes House Floor Vote
Bipartisan proposal would enable VA doctors to recommend medical marijuana to veterans, marking potential breakthrough in federal cannabis policy.
Jushi Holdings Misses Q3 Estimates on Revenue and Earnings
JUSHF reports Q3 GAAP EPS of -$0.10, missing estimates by $0.05, while revenue of $66.4M falls short of projections by $0.58M in challenging cannabis retail environment.
Michigan Cannabis Market Stalls as April Sales Drop 4.3% Year-Over-Year
Michigan's cannabis market shows continued weakness with April sales declining to $258.6M, marking another month of year-over-year contraction despite modest sequential gains.
AI Infrastructure Boom Drives Cannabis Tech Investment Opportunities
Computing demand surge creates new growth vectors for cannabis companies investing in AI-powered cultivation, analytics, and operational efficiency platforms.
Organigram Misses Revenue by 16% as Vape Sales Crater in Q2
OGI reports $43.6M revenue vs $52M consensus as vape weakness and production issues hammer margins, sending adjusted EBITDA down 82% to $900K.
Cannabis ETF Flows Signal Shifting Investor Appetite for Sector Recovery
Portfolio managers reassess cannabis exposure as regulatory momentum builds and sector valuations remain depressed following multi-year selloff.
Former Canadian Senator Pushes Cannabis Act Overhaul
Retired lawmaker advocates for regulatory reforms to Canada's cannabis framework, potentially reshaping the $4.3 billion market amid ongoing industry challenges.
Oklahoma Senate Approves Ibogaine Trials, Expands Psychedelic Access
Oklahoma lawmakers advance breakthrough therapy legislation authorizing state-funded ibogaine trials, marking another step in psychedelic medicine expansion.
Weed Inc Surges 9.8% Despite Penny Stock Volatility Concerns
BUDZ rallies to $0.03 on limited volume as the micro-cap MSO remains highly speculative amid lack of financial transparency.
Cohen Partners With Cannabis Unity Coalition on Federal Reform Push
Tennessee congressman teams with industry coalition to advance federal marijuana policy changes as legislative momentum builds in Washington.
CNS Pharma Gains Highlight Cannabis Medicine Investment Shift
Specialty pharmaceutical companies targeting neurological disorders attract institutional attention as cannabis therapeutics mature into mainstream medicine.
Delivra Health Brands Surges 10.5% as CBD Stock Shows Momentum
DHBUF jumped to $0.14 on modest volume, marking a significant gain for the micro-cap CBD company amid broader sector volatility.
CV Sciences Plunges 12.4% as CBD Stock Hits New Lows
CV Sciences dropped to $0.04 per share amid elevated volume, approaching its 52-week low as the CBD sector faces continued headwinds.
California Clears Drive-Thru Cannabis Sales in Assembly Vote
Assembly approves 55-9 measure allowing licensed retailers to serve customers through drive-thru windows, potentially boosting operational efficiency.
22nd Century Reports Q1 2026 Results: Tobacco Tech Pivot Continues
XXII delivers mixed quarterly performance as company advances reduced-nicotine cigarette commercialization amid ongoing operational restructuring efforts.
Weedmaps Stock Crashes 11% as MAPS Hits New 52-Week Low at $0.39
WM Technology shares plummeted 11.03% on heavy volume, bringing market cap down to $42 million amid ongoing cannabis tech sector challenges.
iAnthus Capital Plunges 11.8% as Bankruptcy Woes Continue
ITHUF shares fell to virtually zero amid ongoing restructuring challenges, with 185,791 shares changing hands despite minimal trading value.
Indiana Pharmacy Board Eyes Cannabis Rescheduling Implementation Strategy
Indiana's pharmacy regulators weigh federal rescheduling implications as conservative states prepare for potential cannabis policy shifts.
Indiana Pharmacy Board Weighs Federal Cannabis Rescheduling Impact
Indiana officials examine how federal marijuana reclassification could trigger state medical cannabis policy changes, potentially opening new market opportunities.